Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
1. autor: | Hoque, Ismoth Ara |
---|---|
Kolejni autorzy: | Azam, Faruque |
Format: | Praca dyplomowa |
Język: | English |
Wydane: |
Brac University
2024
|
Hasła przedmiotowe: | |
Dostęp online: | http://hdl.handle.net/10361/23164 |
Podobne zapisy
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Wydane: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Wydane: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024) -
Molecules associated with the development of lung cancer
od: Rahman, Adree, i wsp.
Wydane: (2023)